Fentanyl 500mcg and Ropivacaine HCl 250mg added to 0 recalled over sterility concerns
- Recall date
- February 8, 2023
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Apollo Care recalls Fentanyl 500mcg (2mcg/mL) and Ropivacaine HCl 250mg (1mg/mL) added to 250mL 0.9% Sodium Chloride, For Epidural Use Only…
- Recall number
- D-0487-2023
- FDA classification
- Class II
- Brand / firm
- Apollo Care
- Sold / distributed
- MO
Why it was recalled
Lack of assurance of sterility: Suspected microbial growth present on external label packaging.
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Fentanyl 500mcg (2mcg/mL) and Ropivacaine HCl 250mg (1mg/mL) added to 250mL 0.9% Sodium Chloride, For Epidural Use Only, Rx only, 3801 Mojave Ct. Suite 101, Columbia, MO 65202, NDC 71170-950-25
Get recall alerts
Free email alert whenever Apollo Care has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Apollo Care